- Professor of Oncology
Departments / Divisions
- Oncology - Cancer Prevention and Control and Viral Oncology
Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.
Molecular biology of Kaposi's sarcoma- and lymphoma-associated human herpesvirus 8; interactions and mechanisms of activity in virus biology and pathogenesis of captured genes encoding signaling and innate immune evasion proteins; development of methods to block viral protein function. ...read more
Research in this laboratory is directed toward understanding the relevance of captured cellular gene homologues to replication and pathogenesis of human herpesvirus-8 (HHV-8), an oncogenic virus associated with endothelial tumor Kaposi’s sarcoma (KS) and B cell malignancies primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). Like other herpesviruses, HHV-8 is able to undergo lytic replication to produce new infectious particles and also to establish latent infections, which for some gamma (lymphotropic) herpesviruses can lead to neoplasia. HHV-8 specifies a homologue of interleukin-6 (vIL-6), three chemokine homologues (vCCL-1, vCCL-2, vCCL-3), and a chemokine receptor-related G protein-coupled receptor (vGPCR) that have been implicated as contributors to HHV-8-associated neoplasia because of their angiogenic, proliferative and anti-apoptotic activities. The virus encodes several other cellular homologues, including four viral interferon regulatory factors (vIRFs 1-4), which function to evade innate cellular defenses against virus infection by inhibiting host IRF functions and via other mechanisms.
Research projects currently being undertaken in this laboratory are aimed at addressing: (1) the mechanisms by which vIL-6 is retained largely intracellularly, in the endoplasmic reticulum (ER), and is able to signal from this compartment; (2) the signal transduction pathways and downstream targets mediating anti-apoptotic signaling by the viral chemokines in PEL and endothelial cells; (3) the mechanistic basis of vGPCR-mediated survival signaling in PEL and endothelial cells; (4) the roles of the v-cytokines and vGPCR in virus replication; (5) the molecular mechanisms by which vIRF-1 associates with pro-apoptotic Bcl-2 family members to inhibit their activities, directly and via their nuclear sequestration, and the relevance of such activity to virus biology and viral pathogenesis. The overall goal of this research is to define the mechanisms of action and importance to viral replication of these proteins to allow assessment of their suitability as therapeutic targets and development of reagents to specifically block their activities.
Choi Y.B., and J.Nicholas. 2008. Human herpesvirus 8 viral chemokines vCCL-1 and vCCL-2 signal through CCR8 in endothelial cells to enhance cell survival and productive virus replication via autocrine and paracrine mechanisms. J Virol. 82:6501-6513.
Chen D., G. Sandford, and J. Nicholas. 2009. Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J Virol. 83:722-733.
Choi Y.B., G. Sandford, and J. Nicholas. 2012. Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry. PLoS Pathogens 8:e1002748.
Cousins, E., and J. Nicholas. 2013. Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability. J Virol. 87:10816-10827.
Chen, D., and J. Nicholas. 2015. Promotion of Endoplasmic Reticulum-Associated Degradation of Procathepsin D by Human Herpesvirus 8-Encoded Viral Interleukin-6. J Virol. 89:7979-7990.